Matsumoto Y - Search Results

1

Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations.

Shinno Y, Goto Y, Watanabe S, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y. Shinno Y, et al. Among authors: matsumoto y. ESMO Open. 2018 Nov 28;3(7):e000399. doi: 10.1136/esmoopen-2018-000399. eCollection 2018. ESMO Open. 2018. PMID: 30559979 Free PMC article.

2

Diagnostic utility of endobronchial ultrasound with a guide sheath under the computed tomography workstation (ziostation) for small peripheral pulmonary lesions.

Matsumoto Y, Izumo T, Sasada S, Tsuchida T, Ohe Y. Matsumoto Y, et al. Clin Respir J. 2017 Mar;11(2):185-192. doi: 10.1111/crj.12321. Epub 2015 Jul 2. Clin Respir J. 2017. PMID: 26072931

3

Mixed response to osimertinib and the beneficial effects of additional local therapy.

Shinno Y, Goto Y, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y. Shinno Y, et al. Among authors: matsumoto y. Thorac Cancer. 2019 Apr;10(4):738-743. doi: 10.1111/1759-7714.12991. Epub 2019 Feb 8. Thorac Cancer. 2019. PMID: 30735003 Free PMC article.

4

Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer.

Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Motoi N, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: matsumoto y. Thorac Cancer. 2019 Apr;10(4):815-822. doi: 10.1111/1759-7714.13004. Epub 2019 Feb 14. Thorac Cancer. 2019. PMID: 30762312 Free PMC article.

5

Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology.

Nakai T, Matsumoto Y, Sasada S, Tanaka M, Tsuchida T, Ohe Y, Motoi N. Nakai T, et al. Among authors: matsumoto y. Jpn J Clin Oncol. 2019 Jun 1;49(6):559-566. doi: 10.1093/jjco/hyz032. Jpn J Clin Oncol. 2019. PMID: 30882147

6

Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer.

Tamura N, Horinouchi H, Sekine K, Matsumoto Y, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y. Tamura N, et al. Among authors: matsumoto y. Thorac Cancer. 2019 May;10(5):1141-1148. doi: 10.1111/1759-7714.13055. Epub 2019 Mar 26. Thorac Cancer. 2019. PMID: 30913364 Free PMC article.

7

Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.

Shibaki R, Murakami S, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Motoi N, Kusumoto M, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: matsumoto y. Med Oncol. 2019 Apr 27;36(6):49. doi: 10.1007/s12032-019-1274-0. Med Oncol. 2019. PMID: 31030326

8

Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis.

Masuda K, Fujiwara Y, Shinno Y, Mizuno T, Sato J, Morita R, Matsumoto Y, Murakami S, Goto Y, Kanda S, Horinouchi H, Yamamoto N, Ohe Y. Masuda K, et al. Among authors: matsumoto y. J Thorac Dis. 2019 Jul;11(7):2965-2972. doi: 10.21037/jtd.2019.07.44. J Thorac Dis. 2019. PMID: 31463126 Free PMC article.

9

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.

Shibaki R, Murakami S, Matsumoto Y, Yoshida T, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Kusumoto M, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: matsumoto y. Cancer Immunol Immunother. 2020 Jan;69(1):15-22. doi: 10.1007/s00262-019-02431-8. Epub 2019 Nov 19. Cancer Immunol Immunother. 2020. PMID: 31745589 Free PMC article.

10

Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.

Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Yoshida T, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Yamamoto N, Ohe Y. Shibaki R, et al. Among authors: matsumoto y. Cancer Immunol Immunother. 2020 Jul;69(7):1229-1236. doi: 10.1007/s00262-020-02539-2. Epub 2020 Mar 10. Cancer Immunol Immunother. 2020. PMID: 32152703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,229 results

Search Page

Filters